Metraipolis › archive › dc_2bdfb0e4447e

Population pharmacokinetics/pharmacodynamics analysis confirming biosimilarity of SB16 to reference denosumab — Europe PMC PMID:40904558

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40904558
DOI
10.3389/fphar.2025.1631034
License (as archived)
solo-consultazione
Archived
2026-11-10T12:03:49.490Z
SHA-256 of the archived text
5edfb64d86b9c8911f76fc93f7e85d5315e75610cf39bd1ab3792a71f5f0a943
Stable URL of this page
https://metraipolis.com/documento/dc_2bdfb0e4447e

How to cite

Population pharmacokinetics/pharmacodynamics analysis confirming biosimilarity of SB16 to reference denosumab — Europe PMC PMID:40904558 — Europe PMC (en), https://europepmc.org/article/MED/40904558 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bdfb0e4447e (Metraipolis archive dc_2bdfb0e4447e, sha256 5edfb64d86b9c8911f76fc93f7e85d5315e75610cf39bd1ab3792a71f5f0a943)
BibTeX
@misc{dc2bdfb0e4447e,
  title = {Population pharmacokinetics/pharmacodynamics analysis confirming biosimilarity of SB16 to reference denosumab — Europe PMC PMID:40904558},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40904558},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bdfb0e4447e; sha256 5edfb64d86b9c8911f76fc93f7e85d5315e75610cf39bd1ab3792a71f5f0a943},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40904558. Agents can read the archived copy with the MCP tool read_document.